Skip to main content
Log in

CASE REPORT: Fatal Cholestatic Liver Failure Associated with Gemcitabine Therapy

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. Coeman D, Verbeken K, Nackaerts M, Demedts MG, Vansteenkiste JF: A fatal case of cholestatic liver failure probably related to gemcitabine. Ann Oncol 11:1503–1504, 2000

    Google Scholar 

  2. Samlowski W, Gundacker H, Kuebler P, Giguere JK, Mills GM, Schuller DE, Ensley JF: Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A southwest oncology group phase II study. Investi New Drugs 19:311–315, 2001

    Google Scholar 

  3. Venook A, Egorin M, Rosner G: Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and leukemia group B 9565. J Clini Oncol 18(14):2780–2787, 2000

    Google Scholar 

  4. Sessa C, Aamadal S, Wolfe I: Gemcitabine in patients with advanced malignant melanoma or gastric cancer. Phase II studies of the EORTC early clinical trials group. Ann Oncol 5:471–472, 1994

    Google Scholar 

  5. Ostapowicz G, Lee WM: Acute hepatic failure: a western perspective. J Gastroenterol Hepatol 15:480, 2000

    Google Scholar 

  6. Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, Stribling R, Crippin JS, Flamm S, Somberg KA, Rosen H, MsCahland TM, Hay JE, Lee WM: Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl and Surg 5:29, 1999

    Google Scholar 

  7. Feldman M, Scharschmidt BF, Sleisenger MH (eds.). Sleisenger's and Fordtran's Gastrointestinal and Liver Disease, 7th ed., WB Saunders, Philadelphia.

  8. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED: Venoocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 4:116, 1984

    Google Scholar 

  9. Rosenberg WMC, Ryley NG, Trowell JM, McGee JO, Chapman RW: Dextro-propoxyphene-induced hepatotoxicity: A report of nine cases. J Hepatol 19:470, 1993

    Google Scholar 

  10. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC: Trends in alternative medicine use in the United States, 1990–1997. JAMA 280:1569, 1998

    Google Scholar 

  11. Winslow LC, Kroll DJ: Herbs as medicines. Arch Intern Med 158:2192, 1998

    Google Scholar 

  12. Angell M, Kassirer JP: Alternative medicine-the risks of untested and unregulated remedies. N Engl J Med 339:839, 1998

    Google Scholar 

  13. Bensoussan A: Complementary medicine-where lies its appeal? Med J Aust 170:247, 1999

    Google Scholar 

  14. Chan TY, Chan JC, Tomlinson B, Critchley JA: Chinese herbal medicines revisited: A Hong Kong perspective, Lancet 342:1532, 1993

    Google Scholar 

  15. Dobbie M, Hofer S, Oberholzer M, et al: Veno-occlusive disease of the liver induced by gemcitabine. Ann Oncol 9:681, 1998

    Google Scholar 

  16. Oettle H, Pelzer U, Hochmuth, K: Phase I trial of gemcitabine (Gemzar), 24-hour infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer. Anticancer Drugs 10:699–704, 1999

    Google Scholar 

  17. Hruban R, Sternberg S, Meyers P, Fleisher M, Menendez-Botet C, Boitnott JK: Fatal thrombocytopenia and liver failure associated with carboplatin therapy. Cancer Invest 9(3):263–268, 1991

    Google Scholar 

  18. Kurita Y, Yokoyama A, Matsui K, Hara N, Nakai Y, Ohhashi Y, Niitani H: Phase I study of gemcitabine hydrochloride combination therapy with cisplatin in the patients with non-small cell lung cancer. Cancer Chemother 26(7):898–907, 1999

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robinson, K., Lambiase, L., Li, J. et al. CASE REPORT: Fatal Cholestatic Liver Failure Associated with Gemcitabine Therapy. Dig Dis Sci 48, 1804–1808 (2003). https://doi.org/10.1023/A:1025415616592

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1025415616592

Navigation